Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Arcturus Therapeutics Holdings Inc.

NASDAQ: ARCT · Life Sciences · 4 alerts · CIK 1768224

Share price
$8.31Close, Nov 16
Market cap
$240M
Shares outstanding
28.82MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Arcturus Therapeutics Holdings Inc. filings on SEC EDGAR ↗

8:32 AM ET 8-K
Capital Raise

Arcturus Therapeutics Holdings Capital Raise of $50M

Arcturus Therapeutics entered into a securities purchase agreement with Meiji Seika Pharma for the sale of 2,466,395 shares of common stock at $20.27 per share, raising $50 million in gross proceeds. The investment was made at an 80% premium to the 30-day average closing price and is part of an expanded collaboration including a license agreement for ARCT-154 technology and a pandemic preparedness MOU in Japan.

Value
$50M
Counterparty
Meiji Seika Pharma Co., Ltd.

“The investment, together with the license agreement and the pandemic preparedness MOU, reflects Meiji’s confidence in our development capabilities and the potential of our technology platform.”

Joseph Payne, President and Chief Executive Officer of Arcturus Therapeutics

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.